European Association for the Study of the Liver

What European Association for the Study of the Liver does

EASL (European Association for the Study of the Liver) is a non-profit professional medical association founded in 1966 in Magdeburg, Germany, now headquartered at 7 rue Daubin, Geneva, Switzerland, and operating under Swiss law. Its stated mission is to promote liver research, the clinical practice of liver disorders, and hepatology as a discipline, serving hepatologists, hepatology researchers, nurses, allied health professionals, trainees and postdocs, young investigators, patients, national liver associations, and European healthcare policymakers. The association runs an integrated ecosystem of scientific publications (Journal of Hepatology in partnership with Elsevier, and JHEP Reports), continuing education (EASL Campus on a Moodle platform hosted by Enovation Solutions, Schools, Masterclasses, the EASL Guidelines App 2.0), flagship events (the annual International Liver Congress drawing 5,000+ delegates, plus monothematic conferences, summits, and workshops), fellowships and mentorships, clinical practice guidelines, advocacy initiatives (the Viral HOPE Programme, EASL-Lancet Liver Commission, Global Liver Advocacy Network, Love Your Liver), and a member-facing portal (MyEASL).

Core technology is conventional rather than proprietary: SugarCRM for member and customer relationship management, m-anage (JMarquardt Technologies) for event and abstract registration, Enovation's Moodle-based EASL Campus for e-learning, SurveyMonkey for surveys, and Ingenico for payment processing, with web analytics from Google Analytics, Clicky, and Yandex Metrica, and PCI-DSS-compliant payment handling. There is no AI/ML infrastructure or proprietary model documented in the source data.

EASL operates a diversified non-profit revenue model anchored on tiered membership fees (€0–€250 per year across Regular, Corresponding, Trainee, Nurse, Allied Health Professional, Patient, Emeritus, Emerging Economy, and Resource-Limited Economy categories), event registration fees for the ILC and other conferences, journal subscriptions (the Journal of Hepatology online access is bundled with membership; a printed copy is €100/year), and diversified support through industry partnerships and Elsevier publishing royalties. Distribution is direct-to-member via easl.eu, the EASL Campus e-learning portal, on-site and online event registration, and a partnership network spanning WHO, AASLD, APASL, ALEH, CGHE, ELPA, and Imperial College London, with the association serving as host of the first WHO Collaborating Centre dedicated to liver disease.

Name

European Association for the Study of the Liver

Legal name

European Association for the Study of Liver

Website

https://easl.eu

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

11–50 employees

Short description

EASL is a Geneva-based, non-profit professional medical association founded in 1966 that serves hepatologists, liver researchers, nurses, allied health professionals, trainees, and patients across Europe and globally through scientific publishing, education, clinical practice guidelines, the annual International Liver Congress, and viral hepatitis elimination advocacy.

Ownership category

akta.pro rank

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Membership Fees: Annual membership fees ranging from €0 to €250 depending on membership category (Regular, Corresponding, Trainee, Nurse, AHP, Patient, Emeritus, Emerging economy, Resource-limited economy, Undergraduate). Membership is valid for 12 months from payment date.
2. Event Registration Fees: Revenue from registration fees for EASL Congress, Summits, Schools, Monothematic Conferences, and Workshops. Members receive reduced fees compared to non-members.
3. Journal Subscriptions: Access to the Journal of Hepatology (printed and online). Members receive online access included in membership; printed copy available for €100/year additional.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

EASL is a non-profit professional medical association that provides membership services, continuing education, scientific publications, clinical practice guidelines, and annual congresses for hepatologists, researchers, nurses, and allied health professionals working in liver disease. Its core paid offerings are tiered annual memberships (€0–€250), the Journal of Hepatology and JHEP Reports peer-reviewed journals, registration-based flagship events such as the International Liver Congress, and structured learning through the EASL Campus e-learning platform and the EASL Guidelines App.

Product overview

EASL (European Association for the Study of the Liver) is a professional medical association serving as the Home of Hepatology. The organization operates an integrated ecosystem of products and services for hepatology professionals. Core offerings include scientific publications (Journal of Hepatology and JHEP Reports), the EASL Campus e-learning platform, the annual International Liver Congress, and the EASL Guidelines App. Additional services encompass educational programs (Schools & Masterclasses, Fellowships, Mentorships), advocacy initiatives (Viral HOPE Programme, Policy Statements, GLAN), member resources (Young Investigators Services, Nurses Learning Centre, Patient Synergies), and digital platforms (MyEASL member portal, event registration, abstract submission). The portfolio is interconnected, with member benefits including access to publications, reduced event fees, educational resources, and funding opportunities.

Differentiator

Problem solved

Functional benefit

Brands

• EASL Campus: Education and library platform providing e-learning, webcasts, e-posters, and educational resources for hepatology
• International Liver Congress (ILC)
• EASL Guidelines App 2.0
• Journal of Hepatology
• JHEP Reports
• Talk Liver To Me
• EASL Studio
• Viral HOPE Programme

Products and services

• EASL Membership Annual membership subscription granting healthcare professionals access to EASL Campus, online Journal of Hepatology, reduced event fees, fellowship and mentorship eligibility, voting rights in the General Assembly (Regular members), and weekly newsletter. Tiered pricing from €0 (resource-limited economies) to €250 (Regular/Corresponding).
• Journal of Hepatology EASL's flagship peer-reviewed scientific journal covering all aspects of hepatology and liver research, distributed globally in partnership with Elsevier Masson with online access included in membership and an optional €100/year printed subscription add-on.
• JHEP Reports EASL's open-access peer-reviewed journal providing rapid publication of scientific findings in liver research and hepatology.
• International Liver Congress (EASL Congress) EASL's flagship annual scientific congress and premier global hepatology meeting, bringing together thousands of hepatologists, researchers, nurses, and industry delegates onsite and online for scientific exchange, education, and networking.
• EASL Schools and Masterclasses Structured educational courses and masterclass programmes providing in-depth hepatology training and professional development for hepatologists, trainees, and allied health professionals, with reduced fees for EASL members.
• EASL Campus Moodle-based education and library platform providing webcasts, e-posters, conference debriefs, slide decks, guidelines, and e-learning resources for hepatology professionals, hosted by Enovation Solutions Ltd.
• EASL Guidelines App 2.0 Mobile application providing access to EASL's advanced liver care clinical practice guidelines, recommendations, and congress applications for hepatology healthcare professionals on iOS and Android.
• EASL Clinical Practice Guidelines Evidence-based clinical practice guidelines and recommendations covering various liver diseases and conditions, published and updated regularly in the Journal of Hepatology and distributed through EASL Campus and the Guidelines App.

Quantifiable outcome

• Viral hepatitis elimination target: 80% reduction in new HCV infections and 65% reduction in mortality by 2030 (WHO goal)
• +1 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration14 records

Partnerships

13 partnerships are on record, tiered flagship, core and minor.

• World Health Organization (WHO)flagshipStrategic or Co-development PartnerEASL collaborates with WHO on viral hepatitis elimination goals. In 2016, WHO adopted the first Global Health Sector Strategy on Viral Hepatitis calling for elimination by 2030. EASL signed the NO-Hep letter promoting worldwide no-hepatitis strategy. The organizations launched the first WHO Collaborating Centre dedicated to liver disease, hosted at Imperial College London with EASL.
• AASLD (American Association for the Study of Liver Diseases)coreStrategic or Co-development PartnerEASL collaborates with AASLD on shared initiatives including joint events and the AASLD-EASL HCC Endpoints Conference. The partnership focuses on advancing hepatology research and clinical practice through international cooperation.
• APASL (Asian Pacific Association for the Study of the Liver)coreStrategic or Co-development PartnerEASL maintains an active partnership with APASL as part of the global hepatology network, collaborating on hepatitis elimination initiatives and shared educational goals.
• ALEH (Latin American Association for the Study of the Liver)coreStrategic or Co-development PartnerEASL collaborates with ALEH, attending their flagship conference and representing EASL at Latin American hepatology events to strengthen international hepatology community ties.
• European Liver Patients' Association (ELPA)coreStrategic or Co-development PartnerEASL works with ELPA on patient advocacy, sharing best practices, and inspiring joint initiatives at national and European levels. ELPA participates in the '10 Asks' liver cancer care advocacy campaign.
• CGHE (Coalition for Global Hepatitis Elimination)coreStrategic or Co-development PartnerEASL collaborates with CGHE as part of the 'Find the Missing Millions' initiative to eliminate viral hepatitis by 2030, working together to advance testing, diagnosis, and treatment access.
• Imperial College LondonflagshipStrategic or Co-development PartnerImperial College London hosts the WHO Collaborating Centre dedicated to liver disease in partnership with EASL and WHO, focusing on advancing liver disease research and policy globally.
• National Liver Associations (Liver Network)coreChannel Partner/ Reseller/ DistributorEASL maintains partnerships with national hepatology associations across Europe through its Liver Network, coordinating policy, advocacy, and educational initiatives at national level.
• Elsevier (Elsevier Masson S.A.S.)coreStrategic or Co-development PartnerEASL partners with Elsevier Masson for publishing the Journal of Hepatology. Elsevier handles journal distribution and subscription services for EASL's flagship publication.
• Enovation Solutions LtdcoreTechnology or IntegrationEnovation Solutions Ltd provides the EASL Campus e-learning platform (Moodle-based), webcast services, e-poster services, and e-learning portal hosting in Ireland.
• JMarquardt Technologies GmbH (m-anage)coreTechnology or IntegrationJMT provides the m-anage software for online and on-site conference registration, membership handling, and event management services for EASL events.
• SugarCRMcoreTechnology or IntegrationEASL uses SugarCRM as its CRM software for managing member and customer relationships and data.
• CongrexminorImplementation/ SI/ Consulting PartnerCongrex handles hotel booking and travel arrangements for some EASL conferences and events.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• European Society for Medical Oncology (ESMO): ESMO is the leading European oncology professional society with a comparable operating model: peer-reviewed journal, annual congress, clinical guidelines, fellowships, and policy advocacy. It is a useful structural peer for benchmarking how a European medical society runs member services, congresses, and policy engagement at scale.
• European Society of Cardiology (ESC): ESC is among the largest European medical specialty societies, running a flagship annual congress, multiple peer-reviewed journals, clinical practice guidelines, and a global fellowship/membership programme. While cardiology is a different specialty, ESC's operating model for congress, journals, and guideline dissemination is directly comparable to EASL's structure.
• American Gastroenterological Association (AGA): AGA is the US-based general gastroenterology professional association that overlaps with hepatology as a sub-specialty. It publishes Gastroenterology and Hepatology journals, runs Digestive Disease Week, and develops clinical guidelines — competing with EASL for hepatology content, abstract submissions, and CME mindshare.
• European Respiratory Society (ERS): ERS is a large European specialty medical society operating a similar ecosystem of journal publications, annual congress (European Respiratory Society International Congress), educational resources, and advocacy for a single organ-system specialty. It benchmarks how a European medical society scales education, guidelines, and congress operations.
• United European Gastroenterology (UEG): UEG is a broader European medical association covering gastroenterology as a whole, headquartered in Vienna. Hepatology sits within gastroenterology, making UEG both a parent-discipline association and a partial substitute/competitor for EASL's clinical guidelines, congress content, and CME offerings in liver disease.

Direct peers

• Asian Pacific Association for the Study of the Liver (APASL): APASL is the Asia-Pacific regional hepatology association, structurally analogous to EASL with a scientific congress, journal, and membership society model focused on liver disease. EASL and APASL are listed as formal partners within the global hepatology network, collaborating on hepatitis elimination and shared educational goals.
• American Association for the Study of Liver Diseases (AASLD): AASLD is the principal North American counterpart to EASL, also founded as a professional medical association dedicated to hepatology research, education, and clinical practice. Both operate peer-reviewed journals (Hepatology vs. Journal of Hepatology), annual flagship congresses (The Liver Meeting vs. International Liver Congress), clinical practice guidelines, and similar tiered membership programmes — and collaborate directly on joint events like the AASLD-EASL HCC Endpoints Conference.

Emerging players

• Coalition for Global Hepatitis Elimination (CGHE): CGHE is a US-based initiative focused specifically on hepatitis elimination, hosted at the Task Force for Global Health. EASL is an explicit partner of CGHE on the 'Find the Missing Millions' initiative, making CGHE a directly comparable stakeholder with overlapping mission, programmatic focus, and partner network in viral hepatitis elimination.

Regional players

• British Society of Gastroenterology (BSG): BSG is the UK national gastroenterology society with overlapping mandate in hepatology education, guidelines, and annual meetings. It is comparable as a regional peer serving hepatologists within a specific European geography and operating a similar journal + congress + membership model.

Others

• European Liver Patients' Association (ELPA): ELPA is a European patient-led umbrella organization for liver disease associations, working closely with EASL on advocacy, awareness campaigns, and the '10 Asks' liver cancer care initiative. While not a direct scientific peer, ELPA is an ecosystem peer that depends on and amplifies EASL's guideline and policy work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/EASLnews
• Facebookfacebook.com/EASLnews
• LinkedInlinkedin.com/company/easlnews

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Association for the Study of the Liver